Login to Your Account



TGA is Drawing a Hard Line Between Biosimilars, Generics

By Mari Serebrov
Washington Editor

Monday, August 5, 2013
regulatory.jpg

Despite their "conceptual parallels," biosimilars are in no way, shape or form to be confused with generics. That's the message the Australian Therapeutics Goods Administration (TGA) sent out repeatedly in its latest guidance on follow-on biologics as it made it clear there would be no automatic substitution down under for biosimilars.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription